Gutwerg Ori
SEC CIK 1846478 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ANIP | ANI PHARMACEUTICALS INC | SVP, GENERICS | 75.5K | — | $2.68M | 29 | 2022-02-15 | 2026-08-10 |
Most active insiders at ANIP, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lalwani Nikhil | Pres, CEO, Dir | — | $5.05M |
| 2 | Walsh Patrick D | Dir | — | $2.32M |
| 3 | CAREY STEPHEN P. | SVP, CFO | — | $1.78M |
| 4 | Mutz Christopher | HEAD OF RARE DISEASE | — | $1.64M |
| 5 | Gassert Chad | SVP - CORP. DEV, STRATEGY | — | $1.31M |
| 6 | Davis Krista | SVP, Chief HR Off | — | $918.6K |
| 7 | Gutwerg Ori | SVP, GENERICS | — | $621.4K |
| 8 | Cook Meredith | SVP, GC, SEC | — | $453.9K |
| 9 | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | — | $393.8K |
| 10 | HAUGHEY THOMAS | Dir | — | $161.8K |
Transactions 29
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-11 20:57 | 2026-08-10 | ANIP | ANI PHARMACEUTICALS INC | Gutwerg Ori | SVP, GENERICS | S - Sale | $77.00 | -3,162 | 75.5K | -4% | -$243.5K | |
| 2026-05-13 16:15 | 2026-05-12 | ANIP | ANI PHARMACEUTICALS INC | Gutwerg Ori | SVP, GENERICS | S - Sale | $79.50 | -2,772 | 78.7K | -3% | -$220.4K | |
| 2026-03-10 | 2026-03-07 | ANIP | ANI PHARMACEUTICALS INC | Gutwerg Ori | SVP, GENERICS | F - Tax | $74.04 | -3,314 | 81.5K | -4% | -$245.4K | |
| 2026-03-04 | 2026-03-03 | ANIP | ANI PHARMACEUTICALS INC | Gutwerg Ori | SVP, GENERICS | S - Sale | $76.50 | -2,060 | 84.8K | -2% | -$157.6K | |
| 2026-03-02 | 2026-02-26 | ANIP | ANI PHARMACEUTICALS INC | Gutwerg Ori | SVP, GENERICS | A - Grant | $77.15 | +13.0K | 89.1K | +17% | +$1.00M | |
| 2026-03-02 | 2026-02-28 | ANIP | ANI PHARMACEUTICALS INC | Gutwerg Ori | SVP, GENERICS | F - Tax | $73.90 | -2,221 | 86.8K | -2% | -$164.1K | |
| M | 2026-02-17 | 2026-02-12+ | ANIP | ANI PHARMACEUTICALS INC | Gutwerg Ori | SVP, GENERICS | F - Tax | $77.04 | -3,663 | 78.0K | -4% | -$282.2K |
| 2026-02-13 | 2026-02-11 | ANIP | ANI PHARMACEUTICALS INC | Gutwerg Ori | SVP, GENERICS | F - Tax | $76.25 | -4,267 | 79.8K | -5% | -$325.4K | |
| 2025-08-14 | 2025-08-12 | ANIP | ANI PHARMACEUTICALS INC | Gutwerg Ori | SVP, GENERICS | S - Sale | $86.53 | -5,873 | 84.0K | -7% | -$508.2K | |
| 2025-05-16 | 2025-05-15 | ANIP | ANI PHARMACEUTICALS INC | Gutwerg Ori | SVP, GENERICS | S - Sale | $60.07 | -881 | 89.9K | -1.0% | -$52.9K | |
| 2025-03-14 | 2025-03-07 | ANIP | ANI PHARMACEUTICALS INC | Gutwerg Ori | SVP, GENERICS | F - Tax | $60.62 | -3,314 | 90.8K | -4% | -$200.9K | |
| D | 2025-03-07 | 2025-03-05 | ANIP | ANI PHARMACEUTICALS INC | Gutwerg Ori | SVP, GENERICS | M - OptEx | $31.49 | +300 | 99.5K | +0.3% | +$9,447 |
| DM | 2025-03-07 | 2025-03-05 | ANIP | ANI PHARMACEUTICALS INC | Gutwerg Ori | SVP, GENERICS | S - Sale+OE | $60.00 | -5,384 | 99.2K | -5% | -$323.0K |
| 2025-03-04 | 2025-02-28 | ANIP | ANI PHARMACEUTICALS INC | Gutwerg Ori | SVP, GENERICS | F - Tax | $61.89 | -1,570 | 99.2K | -2% | -$97.2K | |
| M | 2025-02-18 | 2025-02-14+ | ANIP | ANI PHARMACEUTICALS INC | Gutwerg Ori | SVP, GENERICS | F - Tax | $58.92 | -2,593 | 101.9K | -2% | -$152.8K |
| M | 2025-02-18 | 2025-02-12 | ANIP | ANI PHARMACEUTICALS INC | Gutwerg Ori | SVP, GENERICS | A - Grant | $0.00 | +26.1K | 103.3K | +34% | $0 |
| 2024-06-06 | 2024-06-05 | ANIP | ANI PHARMACEUTICALS INC | Gutwerg Ori | SVP, GENERICS | S - Sale | $67.00 | -2,985 | 77.2K | -4% | -$200.0K | |
| 2024-03-07 | 2024-03-07 | ANIP | ANI PHARMACEUTICALS INC | Gutwerg Ori | SVP, GENERICS | F - Tax | $66.71 | -2,494 | 80.2K | -3% | -$166.4K | |
| 2024-03-01 | 2024-02-29 | ANIP | ANI PHARMACEUTICALS INC | Gutwerg Ori | SVP, GENERICS | F - Tax | $67.67 | -1,570 | 82.7K | -2% | -$106.2K | |
| 2024-02-20 | 2024-02-15 | ANIP | ANI PHARMACEUTICALS INC | Gutwerg Ori | SVP, GENERICS | F - Tax | $57.55 | -1,244 | 84.3K | -1% | -$71.6K | |
| M | 2024-02-16 | 2024-02-14 | ANIP | ANI PHARMACEUTICALS INC | Gutwerg Ori | SVP, GENERICS | A - Grant | $0.00 | +24.6K | 75.7K | +48% | $0 |
| DM | 2023-08-25 | 2023-08-23 | ANIP | ANI PHARMACEUTICALS INC | Gutwerg Ori | SVP, GENERICS | S - Sale+OE | $62.39 | -15.6K | 63.0K | -20% | -$970.9K |
| D | 2023-08-25 | 2023-08-23 | ANIP | ANI PHARMACEUTICALS INC | Gutwerg Ori | SVP, GENERICS | M - OptEx | $31.49 | +13.5K | 76.5K | +21% | +$425.2K |
| M | 2023-04-04 | 2023-02-28 | ANIP | ANI PHARMACEUTICALS INC | Gutwerg Ori | SVP, GENERICS | A - Grant | $0.00 | +28.9K | 63.0K | +85% | $0 |
| M | 2023-03-09 | 2023-03-07 | ANIP | ANI PHARMACEUTICALS INC | Gutwerg Ori | SVP, GENERICS | F - Tax | $44.23 | -2,342 | 34.6K | -6% | -$103.6K |
| 2023-02-17 | 2023-02-15 | ANIP | ANI PHARMACEUTICALS INC | Gutwerg Ori | SVP, GENERICS | F - Tax | $45.04 | -1,275 | 36.4K | -3% | -$57.4K | |
| 2022-04-29 | 2022-04-27 | ANIP | ANI PHARMACEUTICALS INC | Gutwerg Ori | SVP, GENERICS | A - Grant | $0.00 | +6,476 | 37.6K | +21% | $0 | |
| 2022-03-28 | 2022-03-24 | ANIP | ANI PHARMACEUTICALS INC | Gutwerg Ori | SVP, GENERICS | A - Grant | $0.00 | +19.4K | 31.2K | +165% | $0 | |
| 2022-02-17 | 2022-02-15 | ANIP | ANI PHARMACEUTICALS INC | Gutwerg Ori | SVP, GENERICS | F - Tax | $40.25 | -1,167 | 11.7K | -9% | -$47.0K |
Purchase Sale Sale after option exercise All abbreviations